Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Future Considerations When Considering Partial Thymectomy.

The Annals of thoracic surgery·2026

Same author

Less May Be Enough: Clinical Equipoise for Partial Thymectomy.

The Annals of thoracic surgery·2026

Same author

Incidence and clinical outcomes of extended duration support in patients with Impella 5.5 - Analysis from the LOQI Registry.

JHLT open·2026

Same author

Natural History, Treatment, Survival, and Causes of Mortality in Patients With Subsolid and Ground-Glass Nodules.

Chest·2026

Same author

Reply: Importance of clinical context in choice of analytical method.

The Journal of thoracic and cardiovascular surgery·2026

Same author

Clinical outcomes in acute myocardial infarction cardiogenic shock patients supported with a high-flow, surgically implanted micro-axial flow pump.

The Journal of thoracic and cardiovascular surgery·2026

Search research articles

Related Experiment Video

Updated: May 10, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Thymoma: current diagnosis and treatment.

Frank C Detterbeck¹, Ahmad Zeeshan

¹Section of Thoracic Surgery, Yale School of Medicine, Yale University, 330 Cedar St., New Haven, CT 06520, USA. frank.detterbeck@yale.edu

Chinese Medical Journal

|June 18, 2013

Summary

Thymomas are rare anterior mediastinal tumors, often linked to myasthenia gravis. Complete surgical resection is key for good outcomes, with a multimodality approach beneficial for advanced stages.

Area of Science:

Oncology
Thoracic Surgery
Diagnostic Imaging

Background:

Thymomas are rare malignant tumors, comprising approximately half of all anterior mediastinal masses.
A significant association exists between thymomas and myasthenia gravis, affecting about one-third of patients.
Early diagnosis and appropriate staging are crucial for effective management.

Purpose of the Study:

To comprehensively review the clinical presentation, diagnostic methods, staging systems, and treatment strategies for thymoma.
To highlight the importance of established international standards in the management of thymic malignancies.
To provide an overview of current therapeutic approaches, emphasizing surgical resection and multimodality treatments.

Main Methods:

A review of English-language literature on thymoma published within the last 30 years.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Related Experiment Videos

Last Updated: May 10, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Selection of studies containing data relevant to presentation, diagnosis, staging, and treatment.

Emphasis on standards set by the International Thymic Malignancies Interest Group (ITMIG).

Main Results:

Computed tomography (CT) with contrast is the standard for diagnosis, revealing characteristic mass appearances.
The Masaoka-Koga classification is used for staging, guiding treatment decisions.
Complete surgical resection, often via median sternotomy, is the primary treatment and a major prognostic factor.
Multimodality treatment, including chemotherapy and radiation, is beneficial for advanced stages (III and IVa).
Excellent survival rates are observed for completely resected early-stage thymomas.

Conclusions:

Thymic malignancies, though rare, require standardized management approaches for improved patient outcomes.
Surgical resection remains the cornerstone of thymoma treatment.
A multimodality strategy, integrating surgery, chemotherapy, and radiation, is essential for managing a significant proportion of thymoma patients.